Back to Search
Start Over
Plain language summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma.
- Source :
-
Future oncology (London, England) [Future Oncol] 2024; Vol. 20 (18), pp. 1221-1235. Date of Electronic Publication: 2024 Apr 23. - Publication Year :
- 2024
- Subjects :
- Humans
Neoplasm Recurrence, Local
Drug Resistance, Neoplasm
Treatment Outcome
Oligopeptides
Multiple Myeloma therapy
Multiple Myeloma drug therapy
Standard of Care
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Antineoplastic Combined Chemotherapy Protocols adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8301
- Volume :
- 20
- Issue :
- 18
- Database :
- MEDLINE
- Journal :
- Future oncology (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 38651976
- Full Text :
- https://doi.org/10.2217/fon-2023-0954